Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow as a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide (vol 35, pg 3002, 2017)

首页> 外文期刊>Journal of Clinical Oncology >Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow as a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide (vol 35, pg 3002, 2017)

【24h】

Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow as a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide (vol 35, pg 3002, 2017)

机译：使用后移植后环磷酰胺（Vol 35，PG 3002,2017），动员外周血液干细胞与未刺激的骨髓作为用于T细胞 - 填充的储层寄生供体移植的移植源（Vol 35，PG 3002,2017）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Clinical Oncology》 |2019年第6期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow as a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide (vol 35, pg 3002, 2017) [J] . Journal of Clinical Oncology . 2019,第6期

机译：使用后移植后环磷酰胺（Vol 35，PG 3002,2017），动员外周血液干细胞与未刺激的骨髓作为用于T细胞 - 填充的储层寄生供体移植的移植源（Vol 35，PG 3002,2017）
2. Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis [J] . Yu Xiaotong, Liu Liping, Xie Zhenwei, Critical reviews in oncology/hematology . 2019,第期

机译：骨髓与外周血，作为使用后移植后环磷酰胺的成人寄生体内移植的移植源 - 一种系统综述和荟萃分析
3. High Fever Occurring 4 to 5 Days Post-Transplant of Haploidentical Bone Marrow or Peripheral Blood Stem Cells after Reduced-Intensity Conditioning Associated with the Use of Post-Transplant Cyclophosphamide as Prophylaxis for Graft-versus-Host Disease [J] . ODonnell Paul, Raj Kavita, Pagliuca Antonio Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第1期

机译：降低强度的条件后，单倍体骨髓或外周血干细胞移植后4至5天发生高热，并采用移植后环磷酰胺预防移植物抗宿主病
4. Anti-Thymocyte-Globulin (ATG-Fresenius) for Prevention of Acute and Chronic Graft-versus-Host Disease in Pediatric and Adult Recipients of Unrelated Donor Bone Marrow Transplantation [C] . . 2006

机译：抗胸腺细胞球蛋白（ATG-Fresenius）预防无关供体骨髓移植的小儿和成年患者的急性和慢性移植物抗宿主病
5. Bone marrow-derived mesenchymal stem cells as an alternate donor cell source for transplantation in tissue-engineered constructs after traumatic brain injury. [D] . Irons, Hillary R. 2007

机译：骨髓来源的间充质干细胞是创伤性脑损伤后用于组织工程构造的替代供体细胞来源。
6. Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide [O] . Asad Bashey, Mei-Jie Zhang, Shannon R. McCurdy, -1

机译：动员的外周血干细胞与未刺激的骨髓作为移植后使用环磷酰胺进行T细胞充足单倍体供体移植的移植来源
7. Faculty Opinions recommendation of Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide. [O] . Filippo Milano 2020

机译：教师意见推荐动员的外周血干细胞与未刺激的骨髓作为用于使用后分泌后环磷酰胺的T细胞 - 填充储存寄生供体移植的移植源。

Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow as a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide (vol 35, pg 3002, 2017)

著录项

相似文献

相关主题

期刊订阅